These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2591017

  • 21. Studies related to the potential antigenicity of the Bowman-Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeans.
    Maki PA, Paterson Y, Kennedy AR.
    Nutr Cancer; 1994; 22(2):185-93. PubMed ID: 14502847
    [Abstract] [Full Text] [Related]

  • 22. Distribution of the Bowman Birk protease inhibitor in mice following oral administration.
    Billings PC, St Clair WH, Maki PA, Kennedy AR.
    Cancer Lett; 1992 Mar 15; 62(3):191-7. PubMed ID: 1596863
    [Abstract] [Full Text] [Related]

  • 23. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment.
    Armstrong WB, Wan XS, Kennedy AR, Taylor TH, Meyskens FL.
    Laryngoscope; 2003 Oct 15; 113(10):1687-702. PubMed ID: 14520092
    [Abstract] [Full Text] [Related]

  • 24. Effects of the Bowman-Birk protease inhibitor on survival of fibroblasts and cancer cells exposed to radiation and cis-platinum.
    Kennedy CW, Donahue JJ, Wan XS.
    Nutr Cancer; 1996 Oct 15; 26(2):209-17. PubMed ID: 8875558
    [Abstract] [Full Text] [Related]

  • 25. Bowman-Birk protease inhibitor from the seeds of Vigna unguiculata forms a highly stable dimeric structure.
    Rao KN, Suresh CG.
    Biochim Biophys Acta; 2007 Oct 15; 1774(10):1264-73. PubMed ID: 17869196
    [Abstract] [Full Text] [Related]

  • 26. Bowman-Birk inhibitor suppresses production of superoxide anion radicals in differentiated HL-60 cells.
    Ware JH, Wan XS, Kennedy AR.
    Nutr Cancer; 1999 Oct 15; 33(2):174-7. PubMed ID: 10368813
    [Abstract] [Full Text] [Related]

  • 27. Bowman-Birk inhibitor concentrate: a novel therapeutic agent for patients with active ulcerative colitis.
    Lichtenstein GR, Deren JJ, Katz S, Lewis JD, Kennedy AR, Ware JH.
    Dig Dis Sci; 2008 Jan 15; 53(1):175-80. PubMed ID: 17551835
    [Abstract] [Full Text] [Related]

  • 28. Novel alleles among soybean Bowman-Birk proteinase inhibitor gene families.
    Wang Y, Chen X, Qiu L.
    Sci China C Life Sci; 2008 Aug 15; 51(8):687-92. PubMed ID: 18677596
    [Abstract] [Full Text] [Related]

  • 29. Inhibitory effect of Bowman-Birk protease inhibitor on autophagy in MDAMB231 breast cancer cell line.
    Kyani S, Akrami H, Mostafaei A, Akbari S, Salehi Z.
    J Cancer Res Ther; 2021 Aug 15; 17(2):504-509. PubMed ID: 34121699
    [Abstract] [Full Text] [Related]

  • 30. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial.
    Armstrong WB, Kennedy AR, Wan XS, Taylor TH, Nguyen QA, Jensen J, Thompson W, Lagerberg W, Meyskens FL.
    Clin Cancer Res; 2000 Dec 15; 6(12):4684-91. PubMed ID: 11156220
    [Abstract] [Full Text] [Related]

  • 31. Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor.
    Kennedy AR, Beazer-Barclay Y, Kinzler KW, Newberne PM.
    Cancer Res; 1996 Feb 15; 56(4):679-82. PubMed ID: 8630994
    [Abstract] [Full Text] [Related]

  • 32. Soybean-derived Bowman-Birk inhibitor (BBI) blocks HIV entry into macrophages.
    Ma TC, Le Guo, Zhou RH, Wang X, Liu JB, Li JL, Zhou Y, Hou W, Ho WZ.
    Virology; 2018 Jan 01; 513():91-97. PubMed ID: 29040829
    [Abstract] [Full Text] [Related]

  • 33. Polylysine conjugates of Bowman-Birk protease inhibitor as targeted anti-carcinogenic agents.
    Persiani S, Yeung A, Shen WC, Kennedy AR.
    Carcinogenesis; 1991 Jun 01; 12(6):1149-52. PubMed ID: 2044199
    [Abstract] [Full Text] [Related]

  • 34. Selective radioprotection of normal tissues by Bowman-birk proteinase inhibitor (BBI) in mice.
    Dittmann K, Toulany M, Classen J, Heinrich V, Milas L, Rodemann HP.
    Strahlenther Onkol; 2005 Mar 01; 181(3):191-6. PubMed ID: 15756524
    [Abstract] [Full Text] [Related]

  • 35. Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.
    Safavi F, Rostami A.
    Exp Mol Pathol; 2012 Dec 01; 93(3):428-33. PubMed ID: 23022357
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity.
    Malkowicz SB, Liu SP, Broderick GA, Wein AJ, Kennedy AR, Levin RM.
    Neurourol Urodyn; 2003 Dec 01; 22(1):54-7. PubMed ID: 12478602
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.
    Chen YW, Huang SC, Lin-Shiau SY, Lin JK.
    Carcinogenesis; 2005 Jul 01; 26(7):1296-306. PubMed ID: 15746161
    [Abstract] [Full Text] [Related]

  • 40. Potential intracellular target proteins of the anticarcinogenic Bowman Birk protease inhibitor identified by affinity chromatography.
    Billings PC, St Clair W, Owen AJ, Kennedy AR.
    Cancer Res; 1988 Apr 01; 48(7):1798-802. PubMed ID: 3280120
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.